$1.35
-0.04 (-2.88%)
Open$1.38
Previous Close$1.39
Day High$1.39
Day Low$1.30
52W High$2.89
52W Low$1.15
Volume—
Avg Volume1.48M
Market Cap360.29M
P/E Ratio—
EPS$-0.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,096.3% upside
Current
$1.35
$1.35
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 871.70M | 64.47M | 59.12M |
| Net Income | -89,771,764 | 22.72M | 16.50M |
| Profit Margin | -10.3% | 35.2% | 27.9% |
| EBITDA | 2.15M | 29.98M | 25.74M |
| Free Cash Flow | — | 15.79M | 14.78M |
| Rev Growth | +154.1% | +0.6% | +13.8% |
| Debt/Equity | 0.13 | 0.27 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |